Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban versus warfarin for stroke prevention in non-valvular atrial fibrillation
2006-004595-13Phase 3Completed
- Sponsor
- Bayer
- Start
- Dec 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Atrial fibrillation (AFib) comparing Rivaroxaban arm with Warfarin arm (2 arms). Primary endpoint: Composite of stroke and non-central nervous system systemic embolism. Started Dec 2006; status: completed.
02
Drugs
rivaroxabanwarfarin
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on 2006-004595-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004595-13.